Information for the public
Ruxolitinib cream (Opzelura) is available on the NHS for people 12 years and over. It is a possible treatment for non-segmental vitiligo affecting the face, if topical first-line treatments:
- have not worked, or
- are not suitable.
Topical treatments are treatments applied to the skin, such as creams.
If you are not eligible for ruxolitinib cream but are already having it, you should be able to continue until you and your healthcare professional decide when best to stop.
Is this treatment right for me or my child?
Your healthcare professionals should give you clear information, talk with you about your or your child’s options and listen carefully to your views and concerns. Your family can be involved too, if you wish. See our webpage on shared decision making.
Questions to think about
- How well does it work compared with other treatments?
- What are the risks or side effects? How likely are they?
- How will the treatment affect my day-to-day life?
- What happens if the treatment does not work?
- What happens if I do not want to have treatment? Are there other treatments available?
Information and support
The NHS webpage on vitiligo may be a good place to find out more.
These organisations can give you advice and support:
- Vitiligo Support UK, info@vitiligosupport.uk
- Vitiligo Society, 0203 834 9723
- Gene People, 0800 987 8987, helpline@genepeople.org.uk
You can also get support from your local Healthwatch.
NICE is not responsible for the quality or accuracy of any information or advice provided by these organisations.
ISBN: 978-1-4731-9401-4
This page was last updated: